The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2021

Filed:

Aug. 30, 2017
Applicants:

Syed Khizer Rahim Khaderi, Venice, CA (US);

Tsontcho Ianchulev, Harrison, NY (US);

Inventors:

Syed Khizer Rahim Khaderi, Venice, CA (US);

Tsontcho Ianchulev, Harrison, NY (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/00 (2006.01); A61F 9/007 (2006.01); A61M 39/06 (2006.01); A61M 27/00 (2006.01); A61B 5/03 (2006.01); A61M 31/00 (2006.01); A61M 39/02 (2006.01); A61M 39/24 (2006.01);
U.S. Cl.
CPC ...
A61F 9/007 (2013.01); A61F 9/0017 (2013.01); A61F 9/00781 (2013.01); A61M 27/006 (2013.01); A61M 39/06 (2013.01); A61B 5/031 (2013.01); A61F 2210/0014 (2013.01); A61F 2210/0076 (2013.01); A61F 2220/0008 (2013.01); A61F 2230/0041 (2013.01); A61F 2230/0043 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0068 (2013.01); A61F 2250/0096 (2013.01); A61F 2250/0097 (2013.01); A61F 2250/0098 (2013.01); A61M 31/002 (2013.01); A61M 39/0247 (2013.01); A61M 39/24 (2013.01); A61M 2039/0205 (2013.01); A61M 2039/027 (2013.01); A61M 2205/04 (2013.01); A61M 2205/3344 (2013.01);
Abstract

Embodiments of the present specification provide surgical methods and apparatuses to deploy at least one stent through an optic nerve sheath in order to maintain an opening/fenestration for intracranial fluid egress. The surgical method creates a fenestration, an opening, a slit, or a hole, through an optic nerve sheath of a human patient. The fenestration is created in a minimally invasive manner using an applicator, such as an endoscopic visualization apparatus, that includes a stent or shunt for deploying through the fenestration. The presently disclosed specification is indicated to treat papilledema and/or intracranial hypertension and to deliver therapeutic compositions through the optic nerve sheath.


Find Patent Forward Citations

Loading…